DSM2:F-Koninklijke DSM N.V (EUR)

COMMON STOCK | Specialty Chemicals | F

Last Closing Price

EUR 153.55

Change

0.00 (0.00)%

Market Cap

EUR 26.84B

Volume

36.00

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, rest of Europe, North America, Latin America, China, India, Japan, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, enzymes, eubiotics, carotenoids, lipids, and minerals; human nutrition and health products comprising carotenoids, digestive enzymes, nutritional lipids, nutraceuticals, probiotic and prebiotics, human milk oligosaccharides, and vitamins, as well as premix, market-ready solutions, and personalized nutrition; and skin and sun care, hair care, and aroma ingredients. It also provides vitamin and lipid active pharmaceutical ingredients; omega-3 fatty acids; specialty food enzymes, cultures, probiotics, bio-preservation, sugar reduction, and savory taste solutions; and specialty hydrocolloid solutions. The Materials segment provides thermoplastics used in automotive, electrical and electronics, building and construction, medical, food packaging, and consumer goods; and Dyneema, a fiber solution for use in ropes and lines, and outdoor and sports applications. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, plastic and reconstructive surgery, soft tissue, and wound management. It also provides yeast and enzymes for the conversion of starch, corn fiber, and biomass. Koninklijke DSM N.V. has a strategic partnership with Mile High Labs to develop and commercialize science-backed cannabinoid consumer products. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-06-20 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LIN:F Linde plc

N/A

EUR124.81B 52.04 15.25
SJ3:F The Sherwin-Williams Company

N/A

EUR60.63B 35.03 19.27
ECJ:F Ecolab Inc

N/A

EUR50.11B 53.35 24.78
PPQ:F PPG Industries, Inc

N/A

EUR33.67B 33.74 17.56
SIKA:F Sika AG

N/A

EUR31.03B 35.55 25.68
IFF:F International Flavors & Fragra..

N/A

EUR30.56B 105.85 45.26
NI7:F Nippon Paint Holdings Co., Ltd

N/A

EUR29.19B 51.05 0.23
GIN:F Givaudan SA

N/A

EUR29.10B 36.89 25.48
DLY:F LyondellBasell Industries N.V

N/A

EUR28.35B 14.42 9.85
AMC:F Albemarle Corporation

N/A

EUR16.13B 49.48 23.71

ETFs Containing DSM2

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.34% 52% F 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.34% 35% F 33% F
Trailing 12 Months  
Capital Gain 26.33% 44% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.33% 21% F 41% F
Trailing 5 Years  
Capital Gain 183.96% 98% A+ 86% B
Dividend Return 14.28% 39% F 35% F
Total Return 198.23% 70% C- 76% C
Average Annual (5 Year Horizon)  
Capital Gain 24.46% 91% A- 81% B-
Dividend Return 2.18% 31% F 30% F
Total Return 26.64% 61% D- 70% C-
Risk Return Profile  
Volatility (Standard Deviation) 15.04% 94% A 84% B
Risk Adjusted Return 177.12% 81% B- 94% A
Market Capitalization 26.84B 92% A- 92% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 53.13 16% F 17% F
Price/Book Ratio 3.62 31% F 32% F
Price / Cash Flow Ratio 17.96 12% F 16% F
EV/EBITDA 20.58 17% F 19% F
Management Effectiveness  
Return on Equity 5.97% 38% F 51% F
Return on Invested Capital 5.45% 55% F 62% D-
Return on Assets 3.02% 40% F 60% D-
Debt to Equity Ratio 44.75% 68% D+ 51% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.58 88% B+ 82% B-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector